» Articles » PMID: 31907922

Ezh2-dependent H3K27me3 Modification Dynamically Regulates Vitamin D3-dependent Epigenetic Control of CYP24A1 Gene Expression in Osteoblastic Cells

Overview
Journal J Cell Physiol
Specialties Cell Biology
Physiology
Date 2020 Jan 8
PMID 31907922
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Epigenetic control is critical for the regulation of gene transcription in mammalian cells. Among the most important epigenetic mechanisms are those associated with posttranslational modifications of chromosomal histone proteins, which modulate chromatin structure and increased accessibility of promoter regulatory elements for competency to support transcription. A critical histone mark is trimethylation of histone H3 at lysine residue 27 (H3K27me3), which is mediated by Ezh2, the catalytic subunit of the polycomb group complex PRC2 to repress transcription. Treatment of cells with the active vitamin D metabolite 1,25(OH) D , results in transcriptional activation of the CYP24A1 gene, which encodes a 24-hydroxylase enzyme, that is, essential for physiological control of vitamin D3 levels. We report that the Ezh2-mediated deposition of H3K27me3 at the CYP24A1 gene promoter is a requisite regulatory component during transcriptional silencing of this gene in osteoblastic cells in the absence of 1,25(OH) D . 1,25(OH) D dependent transcriptional activation of the CYP24A1 gene is accompanied by a rapid release of Ezh2 from the promoter, together with the binding of the H3K27me3-specific demethylase Utx/Kdm6a and thereby subsequent erasing of the H3K27me3 mark. Importantly, we find that these changes in H3K27me3 enrichment at the CYP24A1 gene promoter are highly dynamic, as this modification is rapidly reacquired following the withdrawal of 1,25(OH) D .

Citing Articles

Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiation.

Dashti P, Lewallen E, Gordon J, Montecino M, van Leeuwen J, Stein G Bone Rep. 2023; 19:101704.

PMID: 37593409 PMC: 10430181. DOI: 10.1016/j.bonr.2023.101704.


1,25(OH)D ameliorates doxorubicin‑induced cardiomyopathy by inhibiting the NLRP3 inflammasome and oxidative stress.

Gu X, Zhao L, Ye J, Chen L, Sui C, Li B Exp Ther Med. 2023; 26(3):413.

PMID: 37559932 PMC: 10407981. DOI: 10.3892/etm.2023.12112.


H3K27me3 Inactivates SFRP1 to Promote Cell Proliferation via Wnt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.

Zhou M, Yu S, Liu Y, Shu S, Xu Y, Liu M Dig Dis Sci. 2023; 68(6):2463-2473.

PMID: 36933113 DOI: 10.1007/s10620-023-07892-7.


Vitamin D and Bone: A Story of Endocrine and Auto/Paracrine Action in Osteoblasts.

van Driel M, van Leeuwen J Nutrients. 2023; 15(3).

PMID: 36771187 PMC: 9919888. DOI: 10.3390/nu15030480.

References
1.
Montecino M, Stein G, Cruzat F, Marcellini S, Stein J, Lian J . An architectural perspective of vitamin D responsiveness. Arch Biochem Biophys. 2007; 460(2):293-9. PMC: 2715940. DOI: 10.1016/j.abb.2006.12.015. View

2.
Chiba N, Suldan Z, Freedman L, Parvin J . Binding of liganded vitamin D receptor to the vitamin D receptor interacting protein coactivator complex induces interaction with RNA polymerase II holoenzyme. J Biol Chem. 2001; 275(15):10719-22. DOI: 10.1074/jbc.275.15.10719. View

3.
Fetahu I, Hobaus J, Kallay E . Vitamin D and the epigenome. Front Physiol. 2014; 5:164. PMC: 4010791. DOI: 10.3389/fphys.2014.00164. View

4.
Agger K, Christensen J, Cloos P, Helin K . The emerging functions of histone demethylases. Curr Opin Genet Dev. 2008; 18(2):159-68. DOI: 10.1016/j.gde.2007.12.003. View

5.
Holmqvist P, Mannervik M . Genomic occupancy of the transcriptional co-activators p300 and CBP. Transcription. 2012; 4(1):18-23. PMC: 3644037. DOI: 10.4161/trns.22601. View